Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse

被引:141
作者
Shi, FD
Flodström, M
Balasa, B
Kim, SH
Van Gunst, K
Strominger, JL
Wilson, SB
Sarvetnick, N
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.121169698
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Quantitative and qualitative defects in CD1-restricted natural killer T cells have been reported in several autoimmune-prone strains of mice, including the nonobese diabetic (NOD) mouse. These defects are believed to be associated with the emergence of spontaneous autoimmunity. Here we demonstrate that both CD1d-null NOD and CD1d-null NOD/BDC2.5 T cell receptor transgenic mice have an accelerated onset and increased incidence of diabetes when compared with CD1d(+/-) and CD1d(+/+) littermates, The acceleration of disease did not seem to result from changes in the T helper (Th)1/Th2 balance because lymphocytes purified from lymphoid organs and pancreatic islets of wild-type and CD1d-null mice secreted equivalent amounts of IFN-gamma and IL-4 after stimulation. In contrast, the pancreata of CD1d-null mice harbored significantly higher numbers of activated memory T cells expressing the chemokine receptor CCR4, Notably, the presence of these T cells was associated with immunohistochemical evidence of increased destructive insulitis, Thus, CD1d-restricted T cells are critically important for regulation of the spontaneous disease process in NOD mice.
引用
收藏
页码:6777 / 6782
页数:6
相关论文
共 32 条
[1]   The NOD mouse model of type 1 diabetes: As good as it gets? [J].
Atkinson, MA ;
Leiter, EH .
NATURE MEDICINE, 1999, 5 (06) :601-604
[2]  
Carnaud C, 1999, J IMMUNOL, V163, P4647
[3]   The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD [J].
Delovitch, TL ;
Singh, B .
IMMUNITY, 1997, 7 (06) :727-738
[4]  
Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO
[5]  
2-E
[6]   Mapping and identification of autoimmunity genes [J].
Encinas, JA ;
Kuchroo, VK .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (06) :691-697
[7]   A defect in interleukin 12-induced activation and interferon γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus [J].
Falcone, M ;
Yeung, B ;
Tucker, L ;
Rodriguez, E ;
Sarvetnick, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :963-972
[8]   NKT cells: facts, functions and fallacies [J].
Godfrey, DI ;
Hammond, KJL ;
Poulton, LD ;
Smyth, MJ ;
Baxter, AG .
IMMUNOLOGY TODAY, 2000, 21 (11) :573-583
[9]   Genetic control of diabetes progression [J].
Gonzalez, A ;
Katz, JD ;
Mattei, MG ;
Kikutani, H ;
Benoist, C ;
Mathis, D .
IMMUNITY, 1997, 7 (06) :873-883
[10]   The temporal importance of TNFα expression in the development of diabetes [J].
Green, EA ;
Flavell, RA .
IMMUNITY, 2000, 12 (05) :459-469